» Articles » PMID: 32679871

Usefulness of F-FDG PET/CT in Patients with Cardiac Implantable Electronic Device Suspected of Late Infection

Overview
Journal J Clin Med
Specialty General Medicine
Date 2020 Jul 19
PMID 32679871
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The presence of a cardiovascular implantable electronic device (CIED) can be burdened by complications such as late infections that are associated with significant morbidity and mortality and require immediate and effective treatment. The aim of this study was to evaluate the role of F-fluorodeoxyglucose positron-emission tomography/computed tomography (F-FDG PET/CT) in patients with suspected CIED infection. Fifteen patients who performed a F-FDG PET/CT for suspicion of CIED infection were retrospectively analyzed; 15 patients, with CIED, that underwent F-FDG PET/CT for oncological reasons, were also evaluated. Visual qualitative analysis and semi-quantitative analysis were performed. All patients underwent standard clinical management regardless F-FDG PET/CT results. Sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) resulted as 90.91%, 75%, 86.67%, 90.91% and 75% respectively. Maximum standardized uptake values (SUV) and semi-quantitative ratio (SQR) were collected and showed differences statistically significant between CIED infected patients and those who were not. Exploratory cut-off values were derived from receiver operating characteristic (ROC) curves for SUV (2.56) and SQR (4.15). This study suggests the clinical usefulness of F-FDG PET/CT in patients with CIED infection due to its high sensitivity, repeatability and non-invasiveness. It can help the clinicians in decision making, especially in patients with doubtful clinical presentation. Future large-scale and multicentric studies should be conducted to establish precise protocols about F-FDG PET/CT performance.

Citing Articles

PET/CT Imaging of Infectious Diseases: Overview of Novel Radiopharmaceuticals.

Calabria F, Guadagnino G, Cimini A, Leporace M Diagnostics (Basel). 2024; 14(10).

PMID: 38786341 PMC: 11120316. DOI: 10.3390/diagnostics14101043.


The Role of the F-FDG PET/CT in the Management of Patients Suspected of Cardiac Implantable Electronic Devices' Infection.

Pisani A, Rubini D, Altini C, Ruta R, Gazzilli M, Sardaro A J Pers Med. 2024; 14(1).

PMID: 38248766 PMC: 10820973. DOI: 10.3390/jpm14010065.


Advances in Molecular Imaging in Infective Endocarditis.

Holcman K, Rubis P, Zabek A, Boczar K, Podolec P, Kostkiewicz M Vaccines (Basel). 2023; 11(2).

PMID: 36851297 PMC: 9967666. DOI: 10.3390/vaccines11020420.


Cardiovascular positron emission tomography: established and emerging role in cardiovascular diseases.

Bansal A, Ananthasubramaniam K Heart Fail Rev. 2022; 28(2):387-405.

PMID: 36129644 DOI: 10.1007/s10741-022-10270-6.


Pacemaker lead rupture in a patient with subacute endocarditis: a case report.

Caratti di Lanzacco L, Wauters A Eur Heart J Case Rep. 2022; 6(2):ytac054.

PMID: 35174311 PMC: 8843865. DOI: 10.1093/ehjcr/ytac054.


References
1.
Baddour L, Epstein A, Erickson C, Knight B, Levison M, Lockhart P . Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010; 121(3):458-77. DOI: 10.1161/CIRCULATIONAHA.109.192665. View

2.
Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

3.
Sandoe J, Barlow G, Chambers J, Gammage M, Guleri A, Howard P . Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British.... J Antimicrob Chemother. 2014; 70(2):325-59. DOI: 10.1093/jac/dku383. View

4.
Tlili G, Amraoui S, Amroui S, Mesguich C, Riviere A, Bordachar P . High performances of (18)F-fluorodeoxyglucose PET-CT in cardiac implantable device infections: A study of 40 patients. J Nucl Cardiol. 2015; 22(4):787-98. DOI: 10.1007/s12350-015-0067-x. View

5.
Bensimhon L, Lavergne T, Hugonnet F, Mainardi J, Latremouille C, Maunoury C . Whole body [(18) F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study. Clin Microbiol Infect. 2010; 17(6):836-44. DOI: 10.1111/j.1469-0691.2010.03312.x. View